Lessons from Adult Stroke Trials

Pediatric Neurology

Volumn 34, Issue 6, 2006, Pages 446-449

  Pavlakis, Steven G ^a   Sacco, Ralph ^b   Levine, Steven R ^a   Meschia, James F ^c   Palesch, Yuko ^d   Tilley, Barbara C ^d   Adams Jr , Harold P ^e  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c MAYO CLINIC   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CEREBROVASCULAR ACCIDENT; DOSE RESPONSE; HEALTH CARE; HEREDITY; HISTOLOGY; HUMAN; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME;

ADULT; CEREBROVASCULAR ACCIDENT; CHILD; CLINICAL TRIALS; HUMANS; RESEARCH DESIGN;

EID: 33744797087     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2005.09.010     Document Type: Article

References (17)

1. Recommendations for preclinical assessment of neuroprotective and recovery drugs. (STAIR). Stroke 30 (1999) 2752-2788
2. Recommendations for clinical trials of acute stroke therapies. (STAIR-2). Stroke 32 (2001) 1598-1606
3. Adams H.P., Bendixen B.H., and Kappelle L.J. Classification of subtypes of acute ischemic stroke. Definitions for the use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke treatment. Stroke 34 (1993) 35-41
4. Cohn M.E., and Marino R.J. The tools of disability outcome research functional status measures. Arch Phys Med Rehabil 81 12 Suppl. 2 (2000) S21-S29
5. Fisher M. Recommendations on how to better organize industry, academics, & government to do more effective future trials. STAIR-3. Stroke 34 (2003) 1539-1546
6. Fisher M. Recommendation on enhancing development, cooperation and approval. STAIR-4. Stroke 36 (2005) 1808-1813
7. Kirkham F.J. Stroke in childhood. Arch Dis Child 81 (1999) 85-89
8. Ganesan V., Prengler M., McShane M., et al. Investigation of risk factors in children with narterial ischemic stroke. Ann Neurol 8 (2003) 167-173
9. Ganesan V., Hogan A., Shack N., Gordon A., Isaacs E., and Kirkham F.J. Outcome after ishemic stroke in childhood. Dev Med Child Neurol 42 (2000) 455-461
10. Nowak-Gottl U., Staeter R., Sebire G., and Kirkham F.J. Antithrombotic drug treatment of pediatric patients with ischemic stroke. Paediatric Drugs 5 (2003) 167-175
11. Pavlakis S.G., Kingsley P., and Bialer M. Stroke in children. Metabolic and genetic issues. J Child Neurol 15 (2000) 308-311
12. deHaan R., Limburg P., Bossuyt J., vander Muelin J., and Aaronson N. The clinical meaning of the Rankin grades after stroke. Stroke 26 (1995) 2027-2030
13. Hacke W., Donnan G., Fieschi C., et al. Outcome with early stroke treatment. pooled analysis of Atlantis, BCASS, NINDS r-TPA trials. Lancet 363 (2004) 768-774
14. Meschia J.F., and Worrall B.B. New advances in identifying genetic anomalies in stroke-prone probands. Curr Neurol Neurosci Rep 4 (2004) 420-426
15. Meschia J.F., Brown Jr. R.D., Brott T.G., Chukwudelunzu F.E., Hardy J., and Rich S.S. The Siblings With Ischemic Stroke Study (SWISS) protocol. BMC Med Genet 3 (2002) 1-8
16. Meschia J.F., Brott T.G., Brown Jr. R.D., et al. The Ischemic Stroke Genetics Study (ISGS) protocol. BMC Neurol 3 (2003) 4-9
17. Palesch Y.Y., and Tilley B.C. An efficient multi-stage, single-arm Phase II futility design for ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 5 Suppl. 1 (2004) 55-56